REPL - long - bottom play - lots of block buys

2月24日

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

This is not a financial advice!

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

Massive block buys!

We need to break 9.0.

Keep an eye on 13.0 level, needs to get broken for a further upmove. You can take partial profits at this level if u want to lock in gains.

SL under 5.7

TP approx. 15.0

Most info on the chart.

Trade carefully!

3月16日

註釋

05:30:27PM
REPL
Block Trade: REPL 635,800 @ $8.53
Signals
Tuesday March 12, 2024
06:28:24PM
REPL
Block Trade: REPL 911,100 @ $8.70